Active	Status	Sponsor type	Region	Phase	Filter
4 Active 0 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Thomas-Rüddel, Daniel
EPOS-1, NCT05033808: Epirubicin for the Treatment of Sepsis & Septic Shock	Recruiting	2	45	Europe	Epirubicin, Placebo	Jena University Hospital, Ruhr University of Bochum, University Medicine Greifswald	Sepsis	10/24	12/24
Rahmel, Tim
EPOS-1, NCT05033808: Epirubicin for the Treatment of Sepsis & Septic Shock	Recruiting	2	45	Europe	Epirubicin, Placebo	Jena University Hospital, Ruhr University of Bochum, University Medicine Greifswald	Sepsis	10/24	12/24
PEPPER, NCT03334006 / 2016-001788-34: Prospective, Randomized Trial of Personalized Medicine with Pentaglobin® After Surgical Infectious Source Control in Patients with Peritonitis	Recruiting	2	200	Europe	Pentaglobin®/Standard of Care	RWTH Aachen University, Biotest	Peritonitis, Sepsis, Septic Shock	09/27	03/28
Nowak, Hartmuth
EPOS-1, NCT05033808: Epirubicin for the Treatment of Sepsis & Septic Shock	Recruiting	2	45	Europe	Epirubicin, Placebo	Jena University Hospital, Ruhr University of Bochum, University Medicine Greifswald	Sepsis	10/24	12/24